Cargando…
Islet Specific Wnt Activation in Human Type II Diabetes
The Wnt pathway effector gene TCF7L2 has been linked to type II diabetes, making it important to study the role of Wnt signaling in diabetes pathogenesis. We examined the expression of multiple Wnt pathway components in pancreases from normal individuals and type II diabetic individuals. Multiple me...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628766/ https://www.ncbi.nlm.nih.gov/pubmed/19165345 http://dx.doi.org/10.1155/2008/728763 |
_version_ | 1782163736992153600 |
---|---|
author | Lee, Seung-Hee Demeterco, Carla Geron, Ifat Abrahamsson, Annelie Levine, Fred Itkin-Ansari, Pamela |
author_facet | Lee, Seung-Hee Demeterco, Carla Geron, Ifat Abrahamsson, Annelie Levine, Fred Itkin-Ansari, Pamela |
author_sort | Lee, Seung-Hee |
collection | PubMed |
description | The Wnt pathway effector gene TCF7L2 has been linked to type II diabetes, making it important to study the role of Wnt signaling in diabetes pathogenesis. We examined the expression of multiple Wnt pathway components in pancreases from normal individuals and type II diabetic individuals. Multiple members of the Wnt signaling pathway, including TCF7L2, Wnt2b, β-catenin, pGSK3β, TCF3, cyclinD1, and c-myc, were undetectable or expressed at low levels in islets from nondiabetic individuals, but were also upregulated specifically in islets of type II diabetic patients. Culture of pancreatic tissue and islet isolation led to Wnt activation that was reversed by the Wnt antagonist sFRP, demonstrating that Wnt activation in that setting was due to soluble Wnt factors. These data support a model in which the Wnt pathway plays a dynamic role in the pathogenesis of type II diabetes and suggest manipulation of Wnt signaling as a new approach to β-cell-directed diabetes therapy. |
format | Text |
id | pubmed-2628766 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-26287662009-01-22 Islet Specific Wnt Activation in Human Type II Diabetes Lee, Seung-Hee Demeterco, Carla Geron, Ifat Abrahamsson, Annelie Levine, Fred Itkin-Ansari, Pamela Exp Diabetes Res Research Article The Wnt pathway effector gene TCF7L2 has been linked to type II diabetes, making it important to study the role of Wnt signaling in diabetes pathogenesis. We examined the expression of multiple Wnt pathway components in pancreases from normal individuals and type II diabetic individuals. Multiple members of the Wnt signaling pathway, including TCF7L2, Wnt2b, β-catenin, pGSK3β, TCF3, cyclinD1, and c-myc, were undetectable or expressed at low levels in islets from nondiabetic individuals, but were also upregulated specifically in islets of type II diabetic patients. Culture of pancreatic tissue and islet isolation led to Wnt activation that was reversed by the Wnt antagonist sFRP, demonstrating that Wnt activation in that setting was due to soluble Wnt factors. These data support a model in which the Wnt pathway plays a dynamic role in the pathogenesis of type II diabetes and suggest manipulation of Wnt signaling as a new approach to β-cell-directed diabetes therapy. Hindawi Publishing Corporation 2008 2009-01-20 /pmc/articles/PMC2628766/ /pubmed/19165345 http://dx.doi.org/10.1155/2008/728763 Text en Copyright © 2008 Seung-Hee Lee et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Lee, Seung-Hee Demeterco, Carla Geron, Ifat Abrahamsson, Annelie Levine, Fred Itkin-Ansari, Pamela Islet Specific Wnt Activation in Human Type II Diabetes |
title | Islet Specific Wnt Activation in Human Type II Diabetes |
title_full | Islet Specific Wnt Activation in Human Type II Diabetes |
title_fullStr | Islet Specific Wnt Activation in Human Type II Diabetes |
title_full_unstemmed | Islet Specific Wnt Activation in Human Type II Diabetes |
title_short | Islet Specific Wnt Activation in Human Type II Diabetes |
title_sort | islet specific wnt activation in human type ii diabetes |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628766/ https://www.ncbi.nlm.nih.gov/pubmed/19165345 http://dx.doi.org/10.1155/2008/728763 |
work_keys_str_mv | AT leeseunghee isletspecificwntactivationinhumantypeiidiabetes AT demetercocarla isletspecificwntactivationinhumantypeiidiabetes AT geronifat isletspecificwntactivationinhumantypeiidiabetes AT abrahamssonannelie isletspecificwntactivationinhumantypeiidiabetes AT levinefred isletspecificwntactivationinhumantypeiidiabetes AT itkinansaripamela isletspecificwntactivationinhumantypeiidiabetes |